Stockscreener 앱 받기
15.53
0.77%
0.10
전일 마감가:
$15.43
열려 있는:
$15.28
하루 거래량:
10.01M
Relative Volume:
3.33
시가총액:
$4.43B
수익:
$1.19B
순이익/손실:
$117.80M
주가수익비율:
48.85
EPS:
0.3179
순현금흐름:
$144.80M
1주 성능:
+1.43%
1개월 성능:
+1.23%
6개월 성능:
-4.32%
1년 성능:
+15.18%
1일 변동 폭
$15.16
$15.66
1주일 범위
$15.16
$16.17
52주 변동 폭
$10.79
$19.85
소테라헬스 Stock (SHC) Company Profile
명칭
Sotera Health Co
전화
440-262-1410
주소
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, WAT, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
15.54 | 4.40B | 1.19B | 117.80M | 144.80M | 0.3179 |
TMO
Thermo Fisher Scientific Inc
|
460.24 | 168.20B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
166.81 | 117.86B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
537.50 | 41.97B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
350.93 | 34.17B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
113.37 | 31.50B | 7.07B | 1.29B | 993.00M | 4.5355 |
소테라헬스 Stock (SHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | 재개 | RBC Capital Mkts | Outperform |
| 2025-12-18 | 개시 | William Blair | Outperform |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-05-05 | 업그레이드 | Goldman | Neutral → Buy |
| 2024-12-06 | 개시 | Goldman | Neutral |
| 2024-05-21 | 개시 | Piper Sandler | Neutral |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-03-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-01-11 | 업그레이드 | Barclays | Underweight → Overweight |
| 2023-01-11 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-09-20 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-09 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-03-02 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-14 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Citigroup | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | JP Morgan | Overweight |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | RBC Capital Mkts | Outperform |
모두보기
소테라헬스 주식(SHC)의 최신 뉴스
Sotera Health (SHC) Launches Secondary Share Offering of 31.84 M - GuruFocus
Sotera Health names new CEO in planned leadership transition - MSN
Goldman Sachs Takes Lead in SHC Offering - GuruFocus
Sotera Health (NASDAQ: SHC) Sponsors sell 31.84M shares, rights end - Stock Titan
Sotera Health’s private equity backers launch secondary offering - Investing.com
Sotera Health’s private equity backers launch secondary offering By Investing.com - Investing.com Canada
Sotera Health Announces Secondary Offering of Common Stock - The Manila Times
Press Release: Sotera Health Announces Secondary Offering of Common Stock - Moomoo
Sotera Health Co stock (US8293551086): Q1 2026 profit rebound on 10% revenue growth - AD HOC NEWS
SHC Technical Analysis & Stock Price Forecast - Intellectia AI
MSN Money - MSN
Why Broyhill May Be Buying More Sotera Health Shares - AOL.com
Sotera Health taps medical industry veteran Alton Shader as next CEO - The Business Journals
A Quick Look at Today's Ratings for Sotera Health Company(SHC.US), With a Forecast Between $18 to $26 - Moomoo
Sotera Health Company (NASDAQ:SHC) Q1 2026 Earnings Call Transcript - Insider Monkey
Wolfe Research lowers Sotera Health stock price target to $19 on valuation - Investing.com
Sotera Health Q1 2026 slides: earnings beat amid segment divergence By Investing.com - Investing.com Australia
Sotera Health Q1 Earnings Call Highlights - Yahoo Finance
Sotera Health (SHC) Q1 2026 lifts profit with 10% revenue growth - Stock Titan
Earnings call transcript: Sotera Health Q1 2026 beats forecasts, stock dips By Investing.com - Investing.com South Africa
Sotera Health Momentum Builds Beyond Nasdaq Futures Trends - Kalkine Media
Sotera Health reaffirms 2026 outlook of $1.233B-$1.251B revenue and names Alton Shader CEO effective May 26 - MSN
Sotera Health Company Q1 2026 Earnings Call Summary - Yahoo Finance
Sotera Health announces a new CEO - Crain's Cleveland
Should Sotera Health’s (SHC) Return to Quarterly Profitability Prompt Action From Investors? - simplywall.st
Sotera Health Q1 2026 slides: earnings beat amid segment divergence - Investing.com
Earnings call transcript: Sotera Health Q1 2026 beats forecasts, stock dips - Investing.com UK
Sotera Health Q1 2026 Earnings Call Transcript - Benzinga
Sotera Health (SHC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Q1 2026 Sotera Health Co Earnings Call Transcript - GuruFocus
Sotera Health (NASDAQ:SHC) Surges 4% After Q1 Earnings Beat and Reaffirmed 2026 Outlook - ChartMill
Sotera Health Company’s (NASDAQ:SHC) Q1 CY2026: Beats On Revenue, Stock Soars - Yahoo Finance
Sotera Health names Viant Medical CEO as new chief executive By Investing.com - Investing.com Australia
Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook - The Manila Times
Sotera Health names Viant Medical CEO as new chief executive - Investing.com
Sotera Health (NASDAQ: SHC) posts Q1 growth and plans CEO change - Stock Titan
Sotera Health Announces Leadership Transition - The Manila Times
Sotera Health picks Viant Medical CEO Alton Shader as new chief - Stock Titan
Sotera Health Co (SHC) Q1 2026 Earnings Report Preview: What To Expect - GuruFocus
Sotera Health faces earnings test as legal overhang eases By Investing.com - Investing.com Australia
Sotera Health faces earnings test as legal overhang eases - Investing.com UK
소테라헬스 (SHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.05%
자본화:
|
볼륨(24시간):